PATENT CLAIM ANALYSIS

Application Number: 16085234
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["424", "130100"]

Abstract:
The present invention provides for a new therapeutic tools capable of treating infectious diseases, in particular, a new pharmaceutical composition comprising an IgM-enriched immunoglobulin preparation for use in the adjunctive treatment of severe Community Acquired Pneumonia (sCAP).

Claim (Index 8):
The immunoglobulin preparation for use according to  claim 5 , wherein said serum lgM, lgG, or lgA level is present at the time of sCAP diagnosis, more particularly is present at least once within 24 hours before to 24 hours after the start of vasopressor therapy or invasive mechanical ventilation.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.16667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13817414', '14529400', '13655686', '15348121', '14778114']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6815212017186281
- 35 USC 102 Novelty (BERT): 0.5209895565793348
- Combined Prediction Score: 0.6654680372046987
- Mean Citation Score: 230.49716
- Max Citation Score: 256.71954
- Similarity Product: 156.3493986257494

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test